Navigation Links
Immunoglobulin Market (PI & CIDP ) Analysis and Forecasts to 2019 in New Research Report at ReportsnReports.com
Date:5/27/2013

Dallas, Texas (PRWEB) May 27, 2013

“Immunoglobulins Market to 2019 Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease” provides in-depth analysis of the global immunoglobulin market. The report analyzes the markets for immunoglobulin products in the US, the top five European countries (the UK, Germany, France, Italy and Spain) and Japan. The revenue and annual cost of therapy are forecast for the key geographies and in seven key therapeutic segments, along with epidemiological data, until 2019. The seven key therapeutic segments are Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Multifocal Motor Neuropathy (MMN), Guillain-Barré Syndrome (GBS), Myasthenia Gravis (MG), Idiopathic Thrombocytopenic Purpura (ITP), and Chronic Lymphocytic Leukemia (CLL). The report (http://www.reportsnreports.com/reports/239437-immunoglobulins-market-to-2019-demand-in-primary-immunodeficiency-pi-and-chronic-inflammatory-demyelinating-polyneuropathy-cidp-potentially-supplemented-by-approvals-for-alzheimers-disease.html) also profiles the marketed products, key pipeline products, and leading companies that could change the market landscape in the forecast period.

The report expects the immunoglobulin market to see a slight increase in its growth rate during the 2012–2019 forecast period. It was worth $3.6 billion in 2012, having grown at a Compound Annual Growth Rate (CAGR) of 6% from 2006. Demand for immunoglobulin products continues to increase due to growing disease awareness and therapeutic usage in a wide range of therapeutic areas. Immunology and neurology are the disciplines that use the most immunoglobulins, while PI and CIDP are the top indications. Geographically, the US is the largest market, commanding a share of over 70% of the global market. 11 new products have been approved in the US since 2006, but as many are for PI or ITP, immunoglobulin usage in the US remains off-label for all other indications.

Baxter, CSL Behring, and Grifols continue to command the top ranks in terms of revenue, and recent approvals of Subcutaneous Immunoglobulins (SCIGs) in the US and Europe will further boost market growth.

Scope

  •     Annualized market data for the immunoglobulin market from 2006 to 2012 and forecast to 2019
  •     Analysis of the seven key therapeutic segments: PI, CIDP, MMN, MG, CLL, GBS and ITP
  •     Analysis of the immunoglobulins markets in the leading global geographies: the US, the top five European countries, and Japan
  •     Market characterization of the immunoglobulin market, covering size, revenue analysis by geography, the annual cost of therapy, and epidemiology
  •     Key drivers and barriers that have a significant impact on the market
  •     Coverage of key marketed products, approved indications, and safety and efficacy profiles
  •     Coverage of the pipeline molecules in various phases of drug development
  •     Competitive profiling of the leading companies: Baxter, Biotest, Bio Products Laboratory, CSL Behring, Grifols, and Octapharma
  •     Key M&A activity and licensing agreements between 2012 and mid-2013 in the global immunoglobulin market
  •     Overview of the immunoglobulin markets in Asia-Pacific and China, covering regulations, key players and marketed products

Reasons To Buy

  •     Align your product portfolio to the markets with high growth potential
  •     Develop market-entry and market-expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
  •     Develop key strategic initiatives by understanding the key focus areas of the leading companies
  •     Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=239437.

Immunoglobulins Market to 2019 - Profiles of Marketed Products:
1.    Privigen
2.    Gammagard S/D
3.    Gammagard Liquid
4.    Octagam 5%
5.    Flebogamma 10% DIF
6.    Gamunex-C
7.    Gammaplex
8.    HyQvia
9.    Bivigam

Explore more reports on Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/.

About US:
ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 200,000+ reports and in-depth studies of 5000+ micro markets. Our database includes reports by leading publishers from across the globe.

Read the full story at http://www.prweb.com/releases/immunoglobulin-market/pi-cidp-analysis-2019/prweb10772086.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency And CIDP Potentially Supplemented by Approval for Alzheimers Disease Available at ResearchMoz.us
2. Majority of states fail to address youth exposure to alcohol marketing
3. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
4. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
5. New Report Video Surveillance Market (2011 – 2016) by MarketsandMarkets
6. Dotcomsecrets is Offering New Opportunities to People Who Want to Become Expert in Localized Internet Marketing
7. 101 Mobility Opens Franchise in Roanoke/Lynchburg Market
8. How MyTownInsurance.com Helps Insurance Carriers Manage their Loss Exposure through On-Line Marketing
9. Discount Supermarkets Tied to Rising Obesity Rates
10. DotComSecrets Invites Professionals to Learn Great Tips On How to Make a Handsome Income By Working As Local Internet Marketing Consultants
11. Heavy Duty Alternators and Starters Expert Elreg Distributors Ltd. Meets Needs of International Market with Launch of Spanish Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... NASHVILLE, Tenn. (PRWEB) , ... August 22, 2017 ... ... Company, is pleased to announce the addition of Zack Tisch as the ... services for the KLAS-ranked healthcare IT consulting firm’s national accounts, from assisting clients ...
(Date:8/22/2017)... ... August 22, 2017 , ... “To Walk Away”: ... a B17 bomber named Edward Koontz. “To Walk Away” is the creation of published ... has published over two hundred manuscripts in chemistry and religion, as well as four ...
(Date:8/22/2017)... ... August 22, 2017 , ... John Stewart ... and Managing Member for t4 Leadership Development & Consulting. He has spent his ... of “success”: physician leadership development, servant leadership, data driven process improvement, and supportive ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... without risk to health and safety. By learning and implementing best practices for ... , In this webinar, attendees will gain a better understanding of a method ...
(Date:8/21/2017)... ... 2017 , ... Five chefs from local senior assisted living homes will serve ... Guests will be able to vote for their favorite Chef among the following: , ... Salad, Feta Cheese Sauce & Garlic Pita Crisp, Greek Mountain Ice Tea , ITALY, ...
Breaking Medicine News(10 mins):
(Date:8/10/2017)... LAKEWOOD, Colo. , Aug. 10, 2017  Physical Rehabilitation ... Therapy, located in Lakewood, Colorado . The ... Jeff Lipkin , PT, DPT with his staff of ... the University of Pittsburgh and brings over 10 years of ... Belmar PT marks the 10th PRN clinic ...
(Date:8/8/2017)...   Second-quarter 2017 ... loss per share from continuing operations ... 16 percent to $110 million ... to $161 million Second-quarter ... operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... Ind. , Aug. 7, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that its Board of Directors has ... for the third quarter of 2017. ... be paid on or about October 27, 2017 to stockholders ... 22, 2017.  Future declarations of dividends are subject to approval ...
Breaking Medicine Technology: